N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide

C21H17N5O2 — CID 11574273

IUPACN-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide
SMILESCC(=O)Nc1cccc(-c2cncc(Nc3cccc(-c4cnco4)c3)n2)c1
InChIInChI=1S/C21H17N5O2/c1-14(27)24-17-6-2-4-15(8-17)19-10-22-12-21(26-19)25-18-7-3-5-16(9-18)20-11-23-13-28-20/h2-13H,1H3,(H,24,27)(H,25,26)
InChIKeyNJENIOUMKVKNRM-UHFFFAOYSA-N
MW371.40 g/mol
LogP4.50
Rot. Bonds5

About N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide

N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide (PubChem CID 11574273) has the molecular formula C21H17N5O2 and a molecular weight of 371.40 g/mol. Its IUPAC name is N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide.

Molecular Properties

Compound NameN-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide
PubChem CID11574273
Molecular FormulaC21H17N5O2
Molecular Weight371.40 g/mol
Exact Mass371.14
IUPAC NameN-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide
SMILESCC(=O)Nc1cccc(-c2cncc(Nc3cccc(-c4cnco4)c3)n2)c1
InChIInChI=1S/C21H17N5O2/c1-14(27)24-17-6-2-4-15(8-17)19-10-22-12-21(26-19)25-18-7-3-5-16(9-18)20-11-23-13-28-20/h2-13H,1H3,(H,24,27)(H,25,26)
InChIKeyNJENIOUMKVKNRM-UHFFFAOYSA-N
XLogP4.50
TPSA92.94 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms28
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500371.40
LogP ≤ 54.50
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-(3-methylphenyl)-5-phenyl-1,3-oxazol-2-amine
CID 5329849
Dgat1-IN-3
CID 16757107
N-{4-[(6-{[3-(1,3-oxazol-5-yl)phenyl]amino}pyrazin-2-yl)oxy]naphthalen-1-yl}acetamide
CID 24863189
N-{5-[(6-{[3-(1,3-oxazol-5-yl)phenyl]amino}pyrazin-2-yl)oxy]naphthalen-1-yl}acetamide
CID 24878671
N,N-dimethyl-2-[3-[4-[2-(1,3-oxazol-2-yl)phenyl]piperazin-1-yl]propylamino]pyridine-3-carboxamide
CID 10526831
N-[3-([1,3]oxazolo[4,5-b]pyridin-2-yl)phenyl]benzamide
CID 696885
N-(3-[1,3]oxazolo[4,5-b]pyridin-2-ylphenyl)-2-phenylacetamide
CID 712921
N-(3-[1,3]oxazolo[4,5-b]pyridin-2-ylphenyl)hexanamide
CID 3245177
(2-Methoxy-6-oxazol-5-yl-pyrimidin-4-yl)-[2-(4-methoxy-phenyl)-ethyl]-amine
CID 11631233
5-phenyl-N-(4-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)butyl)oxazol-2-amine
CID 11711943
N-(6-((2-Methoxyethyl)(methyl)amino)pyridin-3-yl)-2-phenyl-4-(trifluoromethyl)oxazole-5-carboxamide
CID 16112851
1-(3,3-Diphenylpropyl)-1-(2-morpholin-4-ylethyl)-3-[3-(1,3-oxazol-5-yl)phenyl]urea
CID 16112870

Frequently Asked Questions

What is the IUPAC name of N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide?
The IUPAC name of N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide (CID 11574273) is N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide.
What is the SMILES notation for N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide?
The canonical SMILES for N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide is CC(=O)Nc1cccc(-c2cncc(Nc3cccc(-c4cnco4)c3)n2)c1.
What is the InChIKey of N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide?
The InChIKey is NJENIOUMKVKNRM-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H17N5O2/c1-14(27)24-17-6-2-4-15(8-17)19-10-22-12-21(26-19)25-18-7-3-5-16(9-18)20-11-23-13-28-20/h2-13H,1H3,(H,24,27)(H,25,26).
What are the key properties of N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide?
N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide has a molecular weight of 371.40 g/mol, XLogP of 4.50, 5 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[6-[3-(1,3-oxazol-5-yl)anilino]pyrazin-2-yl]phenyl]acetamide is sourced from PubChem (CID 11574273), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).